Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Bobwinson May 04, 2014 12:33pm
218 Views
Post# 22522499

RE:A question for NOPOO

RE:A question for NOPOOI am very happy with my gains on SVA.  But, of course, I didn't buy much because I was going to buy more when the results from the study came out.  I think we expected first results at Xmas 2012!!!!

Low and behold, the stock has tripled without the results.  As I posted in 2012, there is some issue with the trial.  They can't seem to attract enough patients.  The initial goal of 20 patients is pretty low for something that could eventually treat millions of patients.  Certainly the FDA would never approve based on such a low number unless the results were astounding.  I figured that SVA would use this initial trial to prove the concept, post some spectacular results and raise a LOT more money to conduct a bigger trial.  

So far that hasn't happened.  Starting in April 2012, we have ONE patient who has had the pouch for more than 180 days!  And no efficacy results for anyone.  No partial reduction in insulin, no complete reduction of insulin shots, no reports of any kind except one patient has had it for more than 180 days.  Since the enrollment started in July 2012, that seems like a VERY modest achievement.  

I emailed the company but got no response in 2013.  

Personally, I think if the trial was going great, they would have a waiting list of patients wanting to get off daily insulin shots or at least reducing their need for multiple shots per day.  Either the enrollment criteria is very stringent or there is some reason patients aren't eager to participate.  

This stock is a potential moonshot and I already have a three bagger but I want more info!  

Sernova, what is the problem with the trials???  Why can't you enroll more than a handful of people?  Why haven't you released ANY efficiacy results for a trial that started with the first patient implant in 7/12?

How many patients have been implanted?
What percentage dropped out and for what reasons?
How many are currently in the study?
How many had islets implanted?
What is the survival rate for the islets?  Days, months?
Was there any insulin production and what impact did it have on the patient's requirement for insulin shots?
You did tell us ONE person has had the pouch for over 180 days.  

I think the stock has gone up on hope instead of facts.  I'm very surprised by the stock rise given the lack of info.  Please give us some reasons to buy more stock so we can ride the moonshot! More info! 
Bullboard Posts